Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03834662
Title A Trial of AVID200, a Transforming Growth Factor beta (TGFbeta) Inhibitor, in Patients Malignancies
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Formation Biologics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
START Midwest Clinic Grand Rapids Michigan 49546 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Princess Margaret Cancer Centre Toronto M5G 1Z5 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field